-
-
-
-
-
-
-
Spyre Therapeutics announces $300 million public stock offering
-
-
-
-
-
-
-
Guggenheim Reiterates Spyre (SYRE) at Buy, 'optimistic that the company is best-positioned to pioneer longer-acting mAb therapeutics in IBD'
-
-
-
-
-
-
-
Spyre Therapeutics Announces $180 Million Private Placement
-
23,511 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

